Prior authorization for opioid use disorder care.

HB 1112 prohibits insurance companies and health plans from requiring prior authorization for medications treating opioid use disorder. This directly affects patients seeking medication-assisted treatment for opioid addiction and the healthcare providers who prescribe these medications. The bill’s key provision blocks insurers from demanding pre-approval before covering these specific treatments, removing a common administrative barrier. This policy change aims to streamline access to critical care without altering insurance coverage requirements for other treatments. The bill is currently pending in committee after being amended and adopted by a committee report.